Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The prospect for cytokine based therapeutic strategies in rheumatoid arthritis.

× No keyword cloud information.

19 in total

1. Protection against cartilage proteoglycan synthesis inhibition by antiinterleukin 1 antibodies in experimental arthritis.

Authors: F A van de Loo; O J Arntz; I G Otterness; W B van den Berg
Journal: J Rheumatol Date: 1992-03 Impact factor: 4.666

2. Correlation of plasma interleukin 1 levels with disease activity in rheumatoid arthritis.

Authors: J A Eastgate; J A Symons; N C Wood; F M Grinlinton; F S di Giovine; G W Duff
Journal: Lancet Date: 1988-09-24 Impact factor: 79.321

3. Arthritogenic actions of recombinant IL-1 and tumour necrosis factor alpha in the rabbit: evidence for synergistic interactions between cytokines in vivo.

Authors: B Henderson; E R Pettipher
Journal: Clin Exp Immunol Date: 1989-02 Impact factor: 4.330

4. Production of interleukin-1-receptor antagonist during experimental endotoxaemia.

Authors: E V Granowitz; A A Santos; D D Poutsiaka; J G Cannon; D W Wilmore; S M Wolff; C A Dinarello
Journal: Lancet Date: 1991-12-07 Impact factor: 79.321

5. Balance of synovial fluid IL-1 beta and IL-1 receptor antagonist and recovery from Lyme arthritis.

Authors: L C Miller; E A Lynch; S Isa; J W Logan; C A Dinarello; A C Steere
Journal: Lancet Date: 1993-01-16 Impact factor: 79.321

6. Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha.

Authors: M J Elliott; R N Maini; M Feldmann; A Long-Fox; P Charles; P Katsikis; F M Brennan; J Walker; H Bijl; J Ghrayeb
Journal: Arthritis Rheum Date: 1993-12

7. Interleukin 1 receptor antagonist is a member of the interleukin 1 gene family: evolution of a cytokine control mechanism.

Authors: S P Eisenberg; M T Brewer; E Verderber; P Heimdal; B J Brandhuber; R C Thompson
Journal: Proc Natl Acad Sci U S A Date: 1991-06-15 Impact factor: 11.205

8. Characterization of a high molecular weight tumor necrosis factor-alpha mRNA in influenza A virus-infected macrophages.

Authors: H Sprenger; M Bacher; E Rischkowsky; A Bender; M Nain; D Gemsa
Journal: J Immunol Date: 1994-01-01 Impact factor: 5.422

9. Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis.

Authors: J Keffer; L Probert; H Cazlaris; S Georgopoulos; E Kaslaris; D Kioussis; G Kollias
Journal: EMBO J Date: 1991-12 Impact factor: 11.598

10. An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles.

Authors: A G Wilson; N de Vries; F Pociot; F S di Giovine; L B van der Putte; G W Duff
Journal: J Exp Med Date: 1993-02-01 Impact factor: 14.307

3 in total

1. Cytokine therapy in rheumatoid arthritis.

Authors: E N Wardle
Journal: Ann Rheum Dis Date: 1994-12 Impact factor: 19.103

Review 2. Disease-modifying antirheumatic drugs. Using their clinical pharmacological effects as a guide to their selection.

Authors: C G Jackson; H J Williams
Journal: Drugs Date: 1998-09 Impact factor: 9.546

3. Mast cells, cytokines, and metalloproteinases at the rheumatoid lesion: dual immunolocalisation studies.

Authors: L C Tetlow; D E Woolley
Journal: Ann Rheum Dis Date: 1995-11 Impact factor: 19.103

3 in total